From Evidence and Data to the Front Lines of T1DM Management: The Mechanistic and Therapeutic Rationale for Dual SGLT1/2 Inhibition in Adults with Type 1 Diabetes

From Evidence and Data to the Front Lines of T1DM Management: The Mechanistic and Therapeutic Rationale for Dual SGLT1/2 Inhibition in Adults with Type 1 Diabetes


Published

Created by

CMEducation Resources symposium

Related Presenters

Satish K. Garg, MD

Satish K. Garg, MD

Professor of Pediatrics
Secondary Appointment: Professor of Medicine
Director of Adult Diabetes Division
University of Colorado School of Medicine
Denver, CO